DE RUCCI HEALTHY SLEEP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.16 CNY | -0.57% |
|
+1.77% | +15.28% |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 13,248 | 12,200 | 14,068 | - | - |
| Enterprise Value (EV) 1 | 13,248 | 12,200 | 14,068 | 14,068 | 14,068 |
| P/E ratio | 17.7 x | 15.2 x | 15.8 x | 13.6 x | 12.6 x |
| Yield | - | 3.28% | 3% | 3.18% | 4.07% |
| Capitalization / Revenue | 2.28 x | 2.19 x | 2.19 x | 1.86 x | 1.69 x |
| EV / Revenue | 2.28 x | 2.19 x | 2.19 x | 1.86 x | 1.69 x |
| EV / EBITDA | 12.6 x | 10.3 x | 11.5 x | 10.5 x | 9.45 x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Price to Book | 3.04 x | 2.63 x | 2.58 x | 2.31 x | 2.05 x |
| Nbr of stocks (in thousands) | 400,010 | 400,010 | 400,010 | - | - |
| Reference price 2 | 33.12 | 30.50 | 35.16 | 35.16 | 35.16 |
| Announcement Date | 4/24/23 | 4/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | 5,813 | 5,579 | 6,427 | 7,553 | 8,348 |
| EBITDA 1 | - | - | 1,051 | 1,182 | 1,225 | 1,343 | 1,488 |
| EBIT 1 | - | - | 818.9 | 965.2 | 1,056 | 1,227 | 1,335 |
| Operating Margin | - | - | 14.09% | 17.3% | 16.43% | 16.25% | 15.99% |
| Earnings before Tax (EBT) 1 | - | - | 819.4 | 959.3 | 1,054 | 1,226 | 1,333 |
| Net income 1 | 536.3 | 686.4 | 708.9 | 802.3 | 884.6 | 1,034 | 1,117 |
| Net margin | - | - | 12.2% | 14.38% | 13.76% | 13.69% | 13.39% |
| EPS 2 | 1.680 | 1.910 | 1.870 | 2.010 | 2.220 | 2.585 | 2.795 |
| Free Cash Flow | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | 1.000 | 1.055 | 1.117 | 1.430 |
| Announcement Date | 6/22/21 | 6/12/22 | 4/24/23 | 4/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | 19.9% | 17.8% | 17.3% | 17.9% | 17.5% |
| ROA (Net income/ Total Assets) | - | - | 13.8% | - | 12% | 12% | 12.3% |
| Assets 1 | - | - | 5,156 | - | 7,349 | 8,596 | 9,107 |
| Book Value Per Share 2 | - | - | 10.90 | 11.60 | 13.60 | 15.20 | 17.20 |
| Cash Flow per Share 2 | - | - | 1.620 | 4.840 | 2.970 | 3.250 | 4.070 |
| Capex 1 | - | - | 617 | 395 | 197 | 274 | 194 |
| Capex / Sales | - | - | 10.61% | 7.08% | 3.06% | 3.63% | 2.32% |
| Announcement Date | 6/22/21 | 6/12/22 | 4/24/23 | 4/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
35.16
CNY
Average target price
41
CNY
Spread / Average Target
+16.61%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +15.28% | 1.95B | |
| +1.46% | 9.04B | |
| +1.91% | 4.02B | |
| +14.67% | 2.41B | |
| -8.48% | 1.45B | |
| +39.50% | 1.23B | |
| -27.21% | 1.17B | |
| +15.11% | 1.03B | |
| +6.55% | 900M | |
| -8.22% | 839M |
- Stock Market
- Equities
- 001323 Stock
- Financials De Rucci Healthy Sleep Co., Ltd.